A roadmap for supporting the development of advanced therapy medicinal products in a European framework - PubMed
3 hours ago
- #Healthcare Innovation
- #Advanced Therapy Medicinal Products
- #European Regulatory Framework
- ATMPs face barriers to implementation in European health systems due to EU regulations, requiring new regulatory mechanisms and incentives.
- Experts from the European University Hospitals Alliance propose changes at regulatory and organizational levels to promote ATMP development and ensure equitable and fast patient access.
- Solutions need support from regional, national, and EU authorities to have real-world impact, with insights drawn from academic and rare disease ATMP development.
- The EU must strengthen its position in the global ATMP landscape, dominated by the US and China, to foster innovation and competitiveness.